ESC 365 - A novel cardiovascular-kidney-metabolic syndrome mouse model with inducible HFrEF and atherosclerosis

CBS PREMIUM ACCESS

A novel cardiovascular-kidney-metabolic syndrome mouse model with inducible HFrEF and atherosclerosis

Session: Late-breaking science

Topic: Atherosclerosis, Cerebrovascular Diseases, Aneurysm, Restenosis

Speaker: Doctor A. Van Koppen (Den Haag, NL)

Event: Frontiers in CardioVascular Biomedicine 2024

Congress Presentation

Add to my library

About the speaker

Doctor Arianne Van Koppen

TNO Research, Den Haag (Netherlands (The))

2 presentations

0 follower

4 more presentations in this session

Natural IgM antibodies reduce the prothrombotic potential of post-translationally modified collagen

Speaker: Doctor T. Koller (Vienna, AT)

Chronic myocardial infarction heterogeneously alters the response to isoprenaline in the porcine left ventricle

Speaker: Miss A. Perez-Martinez (Zaragoza, ES)

High-throughput approach to identify release mechanisms of proinflammatory extracellular vesicles

Speaker: Ms L. Zisser (AT)

Biomarkers reflecting myocardial, metabolic, and vascular disease processes identify patients with atrial fibrillation at high risk of cardiovascular events: EAST-AFNET 4 biomolecule study.

Speaker: Professor L. Fabritz (Hamburg, DE)

Access the full session

Late-breaking science

Speakers: Doctor A. Van Koppen, Doctor T. Koller, Miss A. Perez-Martinez, Ms L. Zisser, Professor L. Fabritz

About the event

Frontiers in CardioVascular Biomedicine 2024

12 April - 14 April 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources